ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkin's Lymphoma: A Single Center Experience

BACKGROUND: The ESHAP chemotherapy regimen, that is, the combination of the etoposide, methylprednisolone, high-dose cytarabine and cisplatin, has been shown to be active against relapsing or refractory non-Hodgkin's lymphoma (NHL) in previous therapeutic trials. We attempted to determine wheth...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Park, Sang Hyoung, Kim, Shin, Ko, Ok Bae, Koo, Ja Eun, Lee, Danbi, Jeong, Yong Pil, Huh, Jooryung, Kim, Sung-Bae, Kim, Sang We, Lee, Jae-Lyun, Suh, Cheolwon
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Association of Internal Medicine 2006
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890718/
https://ncbi.nlm.nih.gov/pubmed/17017664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.3.159
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi